Compare ARCT & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCT | DAVA |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 220.4M |
| IPO Year | 2019 | 2015 |
| Metric | ARCT | DAVA |
|---|---|---|
| Price | $8.57 | $4.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $24.11 | $13.50 |
| AVG Volume (30 Days) | ★ 315.4K | 216.5K |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.77 | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $3.98 |
| 52 Week High | $24.14 | $20.80 |
| Indicator | ARCT | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 40.04 |
| Support Level | $6.08 | N/A |
| Resistance Level | $8.97 | $7.04 |
| Average True Range (ATR) | 0.44 | 0.22 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 34.76 | 17.43 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.